Science News About Women’s Mental Health

FDA approval of the postpartum depression treatment brexanolone represents the final phase of a bench-to-bedside journey for this drug — a journey that began in the NIMH Intramural Research Program. NIMH experts are available to provide information on postpartum depression and the importance of, and the science underlying, this new drug.

Brain scans reveal that fluctuations in estrogen can trigger atypical functioning in a key brain memory circuit in women with a common version of a gene. Since working memory function is often disturbed in mental disorders, such gene-hormone interactions are suspect mechanisms that may confer risk.

A new study shows that young people with first episode psychosis have a much higher death rate than previously thought. Researchers looked at people aged 16-30 and found that the group died at a rate at least 24 times greater than the same age group in the general population.

Researchers have discovered molecular mechanisms that may underlie a woman’s susceptibility to disabling irritability, sadness, and anxiety in the days leading up to her menstrual period.

Medicare’s new policy supports Collaborative Care and could improve the lives of millions of people with behavioral health conditions.

Soldiers hospitalized with a psychiatric disorder have a higher suicide risk in the year following discharge from the hospital.

NIMH Twitter Chat on Premenstrual Dysphoric Disorder

NIMH Twitter Chat on Postpartum Depression